| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |